JOUNCE THERAPEUTICS, INC. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fc724013-cefe-40f5-8913-814b105bbc1b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-50.9M | 2022-01-01 – 2022-12-31 | evidence 0001640455-23-000024 |
| FY 2021 | $-90.9M | 2021-01-01 – 2021-12-31 | evidence 0001640455-22-000029 |
| FY 2020 | $-43.8M | 2020-01-01 – 2020-12-31 | evidence 0001640455-21-000055 |
| FY 2019 | $56.8M | 2019-01-01 – 2019-12-31 | evidence 0001640455-20-000034 |
| FY 2018 | $-27.4M | 2018-01-01 – 2018-12-31 | evidence 0001640455-19-000021 |
| FY 2017 | $-16.4M | 2017-01-01 – 2017-12-31 | evidence 0001640455-18-000030 |
| FY 2016 | $-13.7M | 2016-01-01 – 2016-12-31 | evidence 0001640455-18-000030 |
| FY 2015 | $-28.5M | 2015-01-01 – 2015-12-31 | evidence 0001640455-18-000030 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).